Meeting Banner
Abstract #0244

Predictive Value of MRI - Perfusion Parameters in Patients with Liver Metastases

MAGNA25Wieland H. Sommer1, Marco Armbruster1, Steven Sourbron1, Maximilian F. Reiser1, Christoph Zech1

1Department of Clinical Radiology, University of Munich, Grohadern Hospital, Munich, Bavaria, Germany

A dynamic contrast enhanced MRI protocol for the liver was established in neuroendocrine tumors with liver metastases. To find the clinical value of DCE-MRI parameters, these were correlated with FDG-PET-CT parameters and clinical parameters. We found that the arterial plasma flow highly correlates with SUV vales from PET-CT and therefore can monitor the metabolism of the metastases. Other parameters correlated with tumor markers or clinical outcome parameters.

Keywords

acquisition additionally agent alpha amylase analyzed appearing appropriately arterial artifacts assessment background better blood breathing charts cholinesterase clinical coefficient collected compartment computed contrast coronal correlate correlated correlation correlations criteria datasets date days defined derived determine dose dual dynamic enhanced especially every examination excluded extracellular flow fraction frilling functional gradient hepatic highly hospital index indexes indirectly inlet intracellular like lipase liver markers material matrix maximal measured metabolism metastases metastasis metastatic mitosis modalities model monitor monitored morphological needed normalized patient patients perfusion placed plasma predictive proven purely quotient radiology receptor reflect registration related resolution response since slices software table temporal therapy tissue tracer transit treatment tumor tumors twist underwent uptake venous vibe visible visual volume